Summary of Webinar
CYP2D6 is an important pharmacogenetics (PGx) gene as it is involved in the metabolism of ~25% of clinically prescribed drugs. Dr. Cyrine-Eliana Haidar at St Jude Children’s Research Hospital will discuss how to use CYP2D6 genetic information to guide drug dosing and improve patient care, with focus on her many years of experience in managing the medications that are important in oncology care, including ondansetron, tamoxifen, select antidepressants and pain medicines.
Cyrine-Eliana Haidar, PharmD.
Clinical Pharmacogenetics Coordinator, St. Jude Children’s Research Hospital